Yang et al. validated the role of miR-16 as a tumor suppressor in glioma and uncovered a novel mechanism of miR-16-mediated inhibition of glioma growth and invasiveness through inhibition of BCL2 and the NF-κB1/MMP-9 signaling pathway [45, 46]. The gene discussed is BCL2; the disease is neoplasm.